Showing results (361-370 of 566) with videos related to

Sort By:
Pageof 57
The Journal of Rheumatology|October 13, 2009
Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndromeErnest H Choy, Lesley M Arnold, Daniel J Clauw, et al.
Arthritis Care & Research|April 24, 2014
Development and validation of the Lupus Impact Tracker: a patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosusMeenakshi Jolly, Cindy P Garris, Rachel A Mikolaitis, et al.
RMD Open|November 2, 2019
Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extensionGerd R Burmester, Vibeke Strand, Andrea Rubbert-Roth, et al.
Journal of Clinical Medicine|April 30, 2021
The Prognostic Value of Pain Phenotyping in Relation to Treatment Outcomes in Patients with Axial Spondyloarthritis Treated in Clinical Practice: A Prospective Cohort StudyRikke Asmussen Andreasen, Lars Erik Kristensen, Kenneth Egstrup, et al.
The Journal of Rheumatology|July 26, 2002
Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formationJohannes Grisar, Peter M Bernecker, Martin Aringer, et al.
Developmental Neuroscience|March 10, 2025
Obsessive-Compulsive Disorder Associated with Autoimmunity in Youth: Clinical Course before and after Rituximab +/- Adjunctive ImmunomodulationJennifer Frankovich, Denise Calaprice, Meiqian Ma, et al.
The Journal of Rheumatology|February 3, 2020
Appraisal of Candidate Instruments for Assessment of the Physical Function Domain in Patients with Psoriatic ArthritisYing Ying Leung, Ana-Maria Orbai, Alexis Ogdie, et al.
RMD Open|March 23, 2017
Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitorsVibeke Strand, Matthew Reaney, Chieh-I Chen, et al.
Arthritis Research & Therapy|June 21, 2018
Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritisVibeke Strand, Laure Gossec, Clare W J Proudfoot, et al.
The Journal of Rheumatology|August 3, 2011
Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working GroupRieke Alten, Christof Pohl, Ernest H Choy, et al.
Pageof 57